Profile
Raymond T.
Keane worked as an Associate at Martin Clearwater & Bell LLP and Wilson Elser Moskowitz Edelman & Dicker LLP.
He then worked as Chief Counsel-Global Marketing at Bristol Myers Squibb Co. and later as Secretary, Chief Compliance Officer & Senior VP at ARIAD Pharmaceuticals, Inc. He then worked as Secretary, Chief Legal & Compliance Officer at Intarcia Therapeutics, Inc. and currently works as Chief Legal Officer at Cullinan Oncology,.
Inc. Keane received his undergraduate degree from Fordham University and his graduate degree from Fordham University School of Law.
Former positions of Raymond T. Keane
Companies | Position | End |
---|---|---|
CULLINAN THERAPEUTICS, INC. | General Counsel | 2022-06-30 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Compliance Officer | 2020-03-31 |
ARIAD PHARMACEUTICALS, INC. | Compliance Officer | 2012-12-31 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2008-04-30 |
Wilson Elser Moskowitz Edelman & Dicker LLP
Wilson Elser Moskowitz Edelman & Dicker LLP Miscellaneous Commercial ServicesCommercial Services Wilson, Elser, Moscowitz, Edelman & Decker LLP provides legal services. It offers litigation, business and financial, insurance and reinsurance, and government relations services. The firm offers its services to the aesthetics law, automotive and motorized vehicle, aviation and aerospace, chemical, construction, energy, environmental, finance, gaming, sweepstakes and contests, healthcare, hospitality, tourism and leisure, insurance and reinsurance, manufacturing, pharmaceutical, professional services, railroad, real estate, retail, sports, technology, and transportation sectors. The company was founded by Thomas W. Wilson Sr. in 1978 and is headquartered in White Plains, NY. | Corporate Officer/Principal | 1987-12-31 |
Training of Raymond T. Keane
Fordham University | Undergraduate Degree |
Fordham University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
CULLINAN THERAPEUTICS, INC. | Health Technology |
Private companies | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Wilson Elser Moskowitz Edelman & Dicker LLP
Wilson Elser Moskowitz Edelman & Dicker LLP Miscellaneous Commercial ServicesCommercial Services Wilson, Elser, Moscowitz, Edelman & Decker LLP provides legal services. It offers litigation, business and financial, insurance and reinsurance, and government relations services. The firm offers its services to the aesthetics law, automotive and motorized vehicle, aviation and aerospace, chemical, construction, energy, environmental, finance, gaming, sweepstakes and contests, healthcare, hospitality, tourism and leisure, insurance and reinsurance, manufacturing, pharmaceutical, professional services, railroad, real estate, retail, sports, technology, and transportation sectors. The company was founded by Thomas W. Wilson Sr. in 1978 and is headquartered in White Plains, NY. | Commercial Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
Martin Clearwater & Bell LLP
Martin Clearwater & Bell LLP Miscellaneous Commercial ServicesCommercial Services Martin Clearwater & Bell LLP is a legal firm that has been providing defense trial counsel and legal advice to various clients for over a century. The private company is based in New York, NY. The company's clients include healthcare providers, corporations, privately-held companies, governmental entities, municipalities, and individuals. | Commercial Services |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Stock Market
- Insiders
- Raymond T. Keane